PharmaCorp Rx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	85	76	63	4	12	-
Market Cap Growth	51.50%	19.91%	1387.38%	-64.51%	-	-
Enterprise Value	64	75	38	2	9	-
Last Close Price	0.49	0.46	0.54	0.21	0.60	-
PS Ratio	4.08	3.64	10.93	-	-	-
PB Ratio	1.63	1.45	2.07	1.87	4.42	-
P/TBV Ratio	3.93	3.50	4.61	1.87	4.42	-
P/FCF Ratio	44.46	39.58	536.42	-	-	-
P/OCF Ratio	42.51	37.85	506.85	-	-	-
EV/Sales Ratio	3.08	3.61	6.54	-	-	-
EV/FCF Ratio	33.52	39.34	321.02	-	-	-
Debt / Equity Ratio	0.09	0.09	0.03	-	-	-
Debt / FCF Ratio	2.37	2.37	8.07	-	-	-
Net Debt / Equity Ratio	-0.41	-0.41	-0.39	-0.99	-1.01	-1.01
Net Debt / EBITDA Ratio	51.45	51.45	8.86	-	-	-
Net Debt / FCF Ratio	-11.12	-11.12	-101.06	4.32	22.74	-622.24
Asset Turnover	0.42	0.42	0.31	-	-	-
Inventory Turnover	6.27	6.27	-	-	-	-
Quick Ratio	4.67	4.67	7.79	48.54	166.01	37.20
Current Ratio	5.15	5.15	8.59	50.24	166.01	37.98
Return on Equity (ROE)	-3.43%	-3.43%	-6.40%	-18.85%	-28.02%	-
Return on Assets (ROA)	-1.54%	-1.54%	-5.29%	-14.29%	-18.85%	-
Return on Capital Employed (ROCE)	-2.10%	-2.10%	-4.70%	-25.40%	-20.70%	-8.20%
Earnings Yield	-1.74%	-1.95%	-1.60%	-11.05%	-4.31%	-
FCF Yield	2.25%	2.53%	0.19%	-12.20%	-1.00%	-
Buyback Yield / Dilution	-53.12%	-53.12%	-303.02%	-1.39%	-23.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.